Company / EPS (Basic)
Steris EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$1.07
FY2025
5-year range
$1.07 / $4.81
FY2021-FY2025
Trend
-57.2%
vs FY2024
Sector context
#76 of 160
Health Care
What the data says
At $1.07, Steris's eps (basic) ranks #76 of 160 in the Health Care sector. EPS (Basic) has declined for 3 consecutive years, from $4.81 in FY2022 to $1.07 in FY2025.
Based on SEC 10-K filings.
1.07 in FY2025 with a 5-year CAGR of -20.7%.
Declined from $4.66 to $1.07 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -39.4%
- 5-Year CAGR
- -20.7%
- 10-Year CAGR
- -
Sector benchmark
#76 of 160 in Health CareTop 47% of 160This company $1.07 Sector average $1.66
▼
-35.4% below sector average
Key checks
Key Insights
- Steris's eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 57.2% year-over-year.
- Ranks #76 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | -57.2% |
| FY2024 | $2.50 | -46.4% |
| FY2023 | $4.66 | -3.1% |
| FY2022 | $4.81 | +34.0% |
| FY2021 | $3.59 | +5.0% |
| FY2020 | $3.42 | +165.1% |
| FY2019 | $1.29 | -64.1% |
| FY2018 | $3.59 | +372.4% |
| FY2017 | $0.76 | -41.1% |
| FY2016 | $1.29 | - |
As of FY2025 · SEC 10-K · Updated Mar 13, 2026